… the AS03 adjuvanted vaccine for prevention of seasonal A/H1N1 … and use of AS03 adjuvanted
pandemic vaccines containing … the risk, if any, associated with the other A/H1N1 2009 …

… group 3 or health or social care workers, followed by children younger … risk of narcolepsy in
adults who received Pandemrix. … Vaccination coverage was low in healthy young adults and …

… narcolepsy and H1N1 vaccines containing AS03® adjuvant in … report in June 2012, from a
schoolchild who received the … , did not support an increased risk of narcolepsy in recipients …

… -cataplexy recognition, we analysed the results taking into account the … to AS03-adjuvanted
vaccine, we found a strong association with narcolepsy-cataplexy in both children and adults. …

… excluded because they received another diagnosis (eg diagnosis of narcolepsy ruled out
clinically or … with mild conditions but this should not be the case for young persons with severe …

… , the adjusted risk for narcolepsy in younger patients was … risk more than 2 years after
vaccination exposure. Using the index date from the patient registry, the adjusted increase in risk …

… we evaluated the risk of narcolepsy following AS03- and MF59-adjuvanted pH1N1 vaccines
in … was that they be representative of individuals receiving pH1N1 vaccination in the general …

… to investigate whether children in England with narcolepsy who received the ASO3 … risk of
narcolepsy after pandemic A/H1N1 2009 influenza vaccination in children and young people …

… risk of narcolepsy in 4–19-year-old individuals within approximately 8 months after Pandemrix
vaccination as compared to unvaccinated individuals … their child received the pandemic …

… of narcolepsy associated with a specific adjuvanted pandemic … and onset in children
younger than 10 years is uncommon. … between narcolepsy and immunisation with H1N1-AS03-P …